2004 Fiscal Year Final Research Report Summary
Defective homologous recombination repair and carcinogenesis
| Project/Area Number |
12213088
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research on Priority Areas
|
| Allocation Type | Single-year Grants |
|---|
| Review Section |
Biological Sciences
|
|---|
| Research Institution | HIROSHIMA UNIVERSITY |
|---|
Principal Investigator |
MIYAGAWA Kiyoshi Hiroshima University, Research Institute for Radiation Biology and Medicine, Professor, 原爆放射線医科学研究所, 教授 (40200133)
|
|---|
| Project Period (FY) |
2000 – 2004
|
| Keywords | homologous recombination / genome instability / DNA repair / breast cancer / chromosomal aberration |
|---|
| Research Abstract |
A defect in homologous recombination repair has been implicated in carcinogenesis because hereditary breast cancer genes BRCA were shown to play an important role in homologous recombination repair. We have investigated a molecular mechanism of homologous recombination repair in human cells. Rad54B, a gene identified as a novel recombination repair gene, exhibits the double-strand DNA-dependent ATPase activity and is required for gene targeting in human cells. XRCC3, a member of Rad51 paralog, is required for homologous recombination via sister chromatids. Additionally, XRCC3 prevents DNA rereplication and endoreduplication, thereby ensuring chromosome integrity. The T241M variant, a genetic polymorphism implicated in cancer risk, exhibits intact recombination repair, but fails to prevent endoreduplication, suggesting that an increase in endoreduplication is associated with cancer risk. A similar phenotype is observed in a resolvase gene Mus81-deficient cells. This aberration is caused by Cyclin B/Cdc2 inhibition by Chk2 activation in response to DNA damage. Thus, the recombination machinery is tightly associated with DNA replication and cell-cycle regulation. This finding suggests that a defect in the DNA metabolic network induces chromosome instability.
|
